Skinner-Smith v. Sec'y of Health & Human Servs.
Decision Date | 18 December 2018 |
Docket Number | No. 14-1212V,14-1212V |
Court | Court of Federal Claims |
Parties | ALICIA SKINNER-SMITH, Petitioner, v. SECRETARY OF HEALTH & HUMAN SERVICES, Respondent. |
Vaccine Act; Motion for Review; 42 U.S.C. § 300aa-11(a)(5)(B); Statutory construction; Louisiana Medical Review Panel Proceedings
Richard Gage, Richard Gage, P.C., Cheyenne, WY, for Petitioner.
Robert P. Coleman, III, Trial Attorney, Torts Branch, Civil Division, United States Department of Justice, Washington, D.C., for Respondent. With him were Gabrielle M. Fielding, Assistant Director, Torts Branch, Civil Division, Catherine E. Reeves, Deputy Director, Torts Branch, Civil Division, C. Salvatore D'Alessio, Acting Director, Torts Branch, and Joseph H. Hunt, Assistant Attorney General, Civil Division.
On December 17, 2014, Petitioner Alicia Skinner-Smith filed a petition for compensation with the National Vaccine Injury Compensation Program, under the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-1-300aa-34 (2012) (Vaccine Act). On June 25, 2018, Special Master Laura Millman of the United States Court of Federal Claims summarily dismissed Mrs. Skinner-Smith's petition for lack of subject matter jurisdiction pursuant to 42 U.S.C. § 300aa-11(a)(5)(B) (2012), which the parties refer to as "Section 11(a)(5)(B)" of the Vaccine Act. Section 11(a)(5)(B) bars a party from filing a petition for compensation in this court "[i]f a plaintiff has pending a civil action for damages for a vaccine-related injury or death." Skinner-Smith v. Sec'y of Health & Human Servs., No. 14-1212V, 2018 WL 3991343, at *3 ( (quoting 42 U.S.C. § 300aa-11(a)(5)(B)). Special Master Millman concluded, in a brief decision, that because Petitioner had, what Special Master Millman defined as a pending proceeding before a medical review panel in Louisiana on the date that Petitioner filed her petition in the above-captioned case, the petition was in "violation" of Section 11(a)(5)(8) of the Vaccine Act. See Skinner-Smith v. Sec'y of Health & Human Servs., 2018 WL 3991343, at *4. On July 25, 2018, Petitioner filed a motion for review pursuant to Rule 23 of the Vaccine Rules of the United States Court of Federal Claims (Vaccine Rules) (2018) in this court to review the Special Master's decision dismissing her petition.
In 1975, the Louisiana State legislature enacted the Louisiana Medical Malpractice Act (MMA), LA. REV. STAT. ANN. § 40:1299.41 et seq., which was later recodified and redesignated in 2015 as LA. REV. STAT. ANN. § 40:1231.1, et seq. (2018). See Mariakis v. N. Oaks Health Sys., 2018-0165, p. 1 n.1 (La. App. 1 Cir. 9/21/18); --- So. 3d ---; 2018 WL 4523956, at *3 ( ).2 The MMA was passed "with the intended purposes of reducing or stabilizing medical malpractice insurance rates and ensuring the availability of affordable medical services to the general public." McGlothlin v. Christus St. Patrick Hosp., 2010-2775, p. 7 (La. 7/1/11), 65 So. 3d 1218, 1225. One of the principal advantages of the MMA is to limit the liability of health care providers who qualify3 under the MMA "for all malpractice claims because of injuries to or death of any one patient" to $100,000.00, plus interest, and "[a]ny amount due from a judgment or settlement or from a final award in an arbitration proceeding" in excess of $100,000.00 "shall be paid from the patient's compensationfund." LA. REV. STAT. ANN. § 40.1231.2(A); see also Sewell v. Doctors Hosp., 600 So. 2d 577, 578 n.1 (La. 1992). In addition, the MMA limits the total amount a claimant can recover "for all malpractice claims for injuries to or death of a patient, exclusive of future medical care and related benefits" to "five hundred thousand dollars plus interest and cost." LA. REV. STAT. ANN. § 40.1231.2(B). The Patient's Compensation Fund (PCF) is a fund comprised of monies stemming from "an annual surcharge" levied on "all health care providers in Louisiana" who qualify under the MMA. Id. at § 40.1231.4(A)-(B). The annual surcharge is collected by and deposited into the PCF by the PCF Oversight Board, which is a nine-member Board appointed by the Governor of Louisiana and established within the Division of Administration of Louisiana, a state executive agency within the State of Louisiana Office of the Governor. See id. at § 40.1231.4(D)(1)(a) () . The PCF Oversight Board also carries out "[t]he functions of collecting, administering, and protecting the fund, including all matters relating to determining surcharge rates, establishing reserves, the evaluating and settlement of claims, and relating to the defense of the fund." Id. at § 40.1231.4(A)(5)(b).
Id. (quoting Everett v. Goldman, 359 So. 2d at 1264); Perritt v. Dona, 2002-2601, p. 8 (La. 7/2/03); 849 So. 2d 56, 61 (); Rhodes v. Schultis, 13-663, p. 6 (La. App. 5 Cir. 4/23/14); 140 So. 3d 331, 336 ( ; Ward v. Vivian Healthcare and Rehab. Ctr., 47,649, p. 5 (La. App. 2 Cir. 5/15/13); 116 So. 3d 870, 874 ( . In addition, if the individual fails to present his or her medical malpractice claim to a medical review panel before filing an action in a court of competent jurisdiction, the medical malpractice lawsuit filed will be dismissed by the court as premature. See Blevins v. Hamilton Med. Ctr., Inc., 2007-127, p. 4 (La. 6/29/07); 959 So. 2d 440, 444 (); see also Williamson v. Hosp. Serv. Dist. No. 1 of Jefferson, 2004-0451, p. 4 (La. 12/1/04); 888 So. 2d 782, 785 () ; Atkinson v. Lammico Ins. Co., 2011-13, p. 3 (La. App. 3 Cir. 5/4/11); 63 So. 3d 1176, 1179 ().
The medical review panel proceeding is initiated when a claimant files his or her "request for review of a malpractice claim or a malpractice complaint," with the Division of Administration of Louisiana, which, as previously noted, is a state executive agency within the Office of the Governor of Louisiana. See LA. REV. STAT. ANN. § 40:1231.8(A)(2)(b)(i) (...
To continue reading
Request your trial